• / Free eNewsletters & Magazine
  • / My Account
Home>Finance>Ceos>Mark Thompson

Mark Thompson

  1. All
  2. 3rd Party
  1. Concordia Healthcare Corp. announces first patients enrolled in Phase 2 clinical trial using Photodynamic Therapy with PHOTOFRIN(R) for patients with mesothelioma

    Concordia Healthcare Corp. announces first patients enrolled in Phase 2 clinical trial using Photodynamic Therapy with PHOTOFRIN(R) for patients with mesothelioma

  2. Equity Fund Launches Are Surprisingly Common Despite Outflows

    We saw some big trend reversals in 2012's fund launches.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.